Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) study

被引:8
|
作者
Vidal-Perez, Rafael [1 ]
Otero-Ravina, Fernando
Franco, Manuel [2 ]
Rodriguez Garcia, Jose M. [3 ]
Linares Stolle, Rosa [4 ]
Esteban Alvarez, Ramona [5 ]
Iglesias Diaz, Cristina [6 ]
Outeirino Lopez, Elena [7 ]
Vazquez Lopez, Maria Jose [5 ]
Ramon Gonzalez-Juanatey, Jose [1 ]
机构
[1] Univ Santiago de Compostela, Dept Cardiol, Hosp Clin, Santiago De Compostela, Spain
[2] Natl Ctr Cardiovasc Res CNIC, Dept Epidemiol Atherothrombosis & Cardiovasc Imag, Madrid, Spain
[3] Pobra do Caraminal Primary Care Ctr, Pobra Do Caraminal, Spain
[4] Bertamirans Primary Care Ctr, Bertamirans, Spain
[5] Rianxo Primary Care Ctr, Rianxo, Spain
[6] Mera Primary Care Ctr, Oleiros, Spain
[7] Novoa Santos Primary Care Ctr, Orense, Spain
关键词
Primary care; Coronary artery disease; Prognosis; Secondary prevention; STABLE ANGINA-PECTORIS; LONG-TERM OUTCOMES; MYOCARDIAL-INFARCTION; CORONARY-DISEASE; PROGNOSIS; FAILURE; RISK; REVASCULARIZATION; GUIDELINES; MANAGEMENT;
D O I
10.1016/j.ijcard.2012.01.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prognosis of chronic patients with established ischemic heart disease (IHD) is not fully understood. The objective was to determine which factors are related to cardiovascular death and hospitalizations in patients with IHD within a primary care network. Materials and methods: A cohort study was carried out by 69 primary care providers in Spain in 2007. Participants were followed up for a mean of 2.2 +/- 0.3 years. 1095 patients were recruited if they had established (at least 1 year of known disease) IHD (myocardial infarction or and stable or unstable angina). Several hypothesized determinants of cardiovascular mortality were studied, using Cox proportional hazard regression models. Subgroup analysis was also performed for participants without cardiovascular admissions within the last year. Results: Mean time since first IHD diagnosis was 7.6 +/- 6.0 years. Annual all-cause mortality rate was 3.25%, with 44 cardiovascular deaths and 119 cardiovascular admissions. The main prognostic factor for cardiovascular death was previous heart failure (hazard ratio [HR] 4.32, 95% confidence interval [CI] 2.30 to 8.11, p<0.001). Recent cardiovascular admission doubled the risk for death (HR 2.01, CI 1.06 to 3.81, p=0.031). Results showed that use of beta blockers and increased physical activity were the main protective factors. Patients without a recent cardiovascular admission showed previous heart failure as the main significant factor for cardiovascular death. Conclusions: Patients with chronic IHD in a primary care setting may need a closer follow-up in the presence of previous conditions such as heart failure. Physical activity and treatment with beta blockers were the factors giving these patients the greatest protection. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:442 / 450
页数:9
相关论文
共 50 条
  • [21] Ischemic heart disease in chronic uremia
    Parfrey, PS
    Foley, RN
    BLOOD PURIFICATION, 1996, 14 (04) : 321 - 326
  • [22] Causal Relationship of Susceptibility Genes to Ischemic Stroke: Comparison to Ischemic Heart Disease and Biochemical Determinants
    Bentley, Paul
    Peck, George
    Smeeth, Liam
    Whittaker, John
    Sharma, Pankaj
    PLOS ONE, 2010, 5 (02):
  • [23] Association between Serum Ferritin and Prognosis in Patients with Ischemic Heart Disease in Intensive Care Units
    Liu, Shun
    Chen, Mingxian
    Tang, Liang
    Li, Xuping
    Zhou, Shenghua
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [24] Factors Determining Prognosis of Patients With Stable Ischemic Heart Disease (Results of a Five Years Prospective Study)
    Komarov, A. L.
    Shakhmatova, O. O.
    Ilyushchenko, T. A.
    Dzhalilova, G. V.
    Deev, A. D.
    Panchenko, E. P.
    KARDIOLOGIYA, 2012, 52 (01) : 4 - 14
  • [25] Myocardial Revascularization in Patients With Chronic Ischemic Heart Disease Combined With Chronic Obstructive Pulmonary Disease
    Zafiraki, V. K.
    Skaletsky, K. V.
    Kosmacheva, E. D.
    Shulzhenko, L. V.
    Ramazanov, J. M.
    Omarov, A. A.
    KARDIOLOGIYA, 2016, 56 (01) : 51 - 55
  • [26] Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: Data from the Heart and Soul Study
    Beatty, Alexis L.
    Zhang, Mary H.
    Ku, Ivy A.
    Na, Beeya
    Schiller, Nelson B.
    Whooley, Mary A.
    ATHEROSCLEROSIS, 2012, 220 (02) : 587 - 592
  • [27] Prognostication of long-term outcomes for patients with ischemic heart disease
    Umbrasiene, Jelena
    Jankauskiene, Edita
    Kupstyte, Nora
    Babarskiene, Marija Rata
    Vencloviene, Jone
    Gustiene, Olivija
    MEDICINA-LITHUANIA, 2010, 46 (10): : 700 - 706
  • [28] Cardiovascular magnetic resonance in ischemic heart disease
    Bernard, Monique
    Jacquier, Alexis
    Kober, Frank
    FUTURE CARDIOLOGY, 2014, 10 (04) : 487 - 496
  • [29] HYPERTROPHIC CARDIOMYOPATHY AND ISCHEMIC HEART DISEASE. VARIANTS OF COMBINATION PATHOLOGY
    Kaplunova, V. Yu
    Shakaryants, G. A.
    Kozhevnikova, M., V
    Ilgisonis, I. S.
    Privalova, E., V
    Khabarova, N., V
    Naymann, Yu., I
    Belenkov, Yu. N.
    Shakaryants, V. A.
    KARDIOLOGIYA, 2017, 57 (12) : 16 - 24
  • [30] Using machine learning to predict acute myocardial infarction and ischemic heart disease in primary care cardiovascular patients
    Salet, N.
    Gokdemir, A.
    Preijde, J.
    van Heck, C. H.
    Eijkenaar, F.
    PLOS ONE, 2024, 19 (07):